Jerome P. Richie

Brigham and Women's Hospital

Papers

2

Total Citations

217

H-Index

2

About

Jerome P. Richie is a pioneering urologic surgeon and researcher whose work has fundamentally shaped the management of genitourinary malignancies, particularly prostate and kidney cancers. His major contributions center on critically evaluating surgical outcomes and advancing less invasive treatment paradigms. In his highly cited 2009 analysis (147 citations), Richie provided a rigorous examination of minimally invasive surgery and active surveillance for kidney cancer, helping to establish evidence-based guidelines that prioritize patient quality of life without compromising oncologic control. His 2010 study comparing radical retropubic prostatectomy to robotic-assisted laparoscopic prostatectomy (70 citations) offered crucial insights into positive surgical margin rates, directly influencing surgical technique and patient counseling. A former chief of urology at Brigham and Women’s Hospital and the Elliott Carr Cutler Professor of Surgery at Harvard Medical School, Richie has been a leading voice in urologic oncology for decades. His work has not only advanced surgical precision but also championed the shift toward personalized, risk-adapted treatment strategies—profoundly impacting how clinicians and patients navigate the complexities of prostate and kidney cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
217
Total Citations
109
Avg Citations/Paper
🏆 Most Cited Paper
A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer
147 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago